Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04019444
What this trial is testing

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

Who this might be right for
RabiesRabies Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT01119625
What this trial is testing

Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 238
Early research (Phase 1)Study completedNCT06507553
What this trial is testing

Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

Who this might be right for
InfluenzaHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 400
Early research (Phase 1)Study completedNCT06375512
What this trial is testing

Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Who this might be right for
Herpes Zoster
Shenzhen Shenxin Biotechnology Co., Ltd 150
Testing effectiveness (Phase 2)Ended earlyNCT05327816
What this trial is testing

Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
Janssen Vaccines & Prevention B.V. 132
Testing effectiveness (Phase 2)Study completedNCT04551547
What this trial is testing

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 552
Testing effectiveness (Phase 2)Study completedNCT00854685
What this trial is testing

Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Who this might be right for
Rheumatoid Arthritis
Arana Therapeutics Ltd 27
Testing effectiveness (Phase 2)Study completedNCT02628444
What this trial is testing

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 1,050
Post-approval studies (Phase 4)Study completedNCT04133584
What this trial is testing

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Who this might be right for
Seasonal InfluenzaHand, Foot and Mouth Disease
Zhejiang Provincial Center for Disease Control and Prevention 1,134
Early research (Phase 1)Ended earlyNCT04993443
What this trial is testing

First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036

Who this might be right for
Asthma
Syneos Health 40
Early research (Phase 1)Study completedNCT03462108
What this trial is testing

Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates

Who this might be right for
Safety Issues
PT Bio Farma 100
Testing effectiveness (Phase 2)Study completedNCT01504347
What this trial is testing

Phase 1/2 Lyme Vaccine Study

Who this might be right for
Prophylaxis of Lyme Borreliosis
Baxalta now part of Shire 1,630
Large-scale testing (Phase 3)Study completedNCT03197376
What this trial is testing

Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

Who this might be right for
Pneumonia, Pneumococcal
PATH 2,250
Early research (Phase 1)Study completedNCT01632332
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage II Breast Cancer+3 more
Mayo Clinic 22
Early research (Phase 1)Study completedNCT01443663
What this trial is testing

Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 69
Large-scale testing (Phase 3)Study completedNCT01948193
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 177
Testing effectiveness (Phase 2)Study completedNCT02547649
What this trial is testing

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 690
Large-scale testing (Phase 3)Study completedNCT05073315
What this trial is testing

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 425
Testing effectiveness (Phase 2)Study completedNCT00491985
What this trial is testing

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Who this might be right for
InfluenzaOrthomyxoviridae InfectionsInfluenza A Virus Infection
Sanofi Pasteur, a Sanofi Company 240
Post-approval studies (Phase 4)Study completedNCT00760825
What this trial is testing

Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children

Who this might be right for
Vibrio Cholerae
International Vaccine Institute 200
Next Page